Human SHISA3 HEK293 Overexpression Lysate from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
Human SHISA3 HEK293 Overexpression Lysate

Get Pricing

Description

SHISA3(high)CLL are characterized by a restrained activation of Wnt signaling and sensibility to lenalidomide-induced apoptosis. SHISA3 promoter hypermethylation might increase the risk of LSCC through regulation of gene expression and is a potential and prognostic biomarker for LSCC. Shisa3 is a novel tumor suppressor identified in lung cancer. SHISA3 gene is epigenetically inactivated in a substantial fraction of CRC, and its hypermethylation is of prognostic significance in predicting clinical outcome.

This Human SHISA3 overexpression lysate was created in HEK293 Cells and intented for use as a Western blot (WB) positive control. Purification of SHISA3 protein from the overexpression lysate was verified